PharmaCyte Biotech, Inc. - Common Stock - Bilanço (NASDAQ:PMCB)

Financials

Toplam varlıklar 7.4 M90.62 M73.28 M59.9 M55.17 M Toplam yükümlülükler 724.78 K704.37 K586.58 K20.39 M3.28 M Toplam özsermaye 6.68 M89.92 M72.69 M27.65 M51.89 M Toplam yükümlülükler ve hissedarların özsermayesi 7.4 M90.62 M73.28 M59.9 M55.17 M Toplam borç 0———— Net borç -2.2 M————

PMCB

Financials

Haberler

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232

Pharmacyte Biotech CEO Silverman buys $80k in shares

Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Autodesk (NASDAQ:ADSK), Ambarella (NASDAQ:AMBA)

PharmaCyte Biotech hisseleri Femasys hisselerinin başarılı satışı sonrası yükseldi

PharmaCyte Biotech stock soars after successful Femasys stake sale

PharmaCyte Biotech closes $7 million financing to strengthen position

PharmaCyte Biotech secures $7 million in private placement financing